[In-hospital and remote results of the use of sirolimus coated coronary stent CYPHER].
Stents were implanted to 554 previously non-revascularized patients in 703 injured coronary segments; 32% of stented stenoses were complicated; 23% of patients received 2-4 stents. Immediate success was 100% with no cases of acute stent thrombosis. Rate of in-hospital subacute thrombosis and non-Q-wave myocardial infarction was 0.2%. Survival without restenosis, angina, myocardial infarction and repeat revascularization during follow up (mean duration 257+/-107 days) was 94%, restenosis rate -- 5.6%. Six patients with in-stent restenosis were successfully revascularized. All 108 patients followed for 27 months were alive by the end of this term.
B
B
Tiriaki
I V
IV
Pershukov
I V
IV
Levitskiĭ
V V
VV
Lopukhova
Sh T
ShT
Zhamgyrchiev
A N
AN
Samko
Iu A
IuA
Karpov
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D019917:Blood Vessel Prosthesis Implantation / Q000295:instrumentation*; D020099:Coated Materials, Biocompatible; D017023:Coronary Angiography; D023903:Coronary Restenosis / Q000517:prevention & control; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007297:Inpatients; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000000981:diagnostic imaging / Q000601:surgery*; D011474:Prosthesis Design; D012189:Retrospective Studies; D020123:Sirolimus / Q000627:therapeutic use*; D015607:Stents; D013997:Time Factors; D016896:Treatment Outcome
D020099:Coated Materials, Biocompatible; D007166:Immunosuppressive Agents; D020123:Sirolimus